{"university":{"openalex_id":"I155781252","name":"University of South Carolina"},"topic":"age-crosslink-breakers","total_matching":8,"offset":0,"next_offset":null,"records":[{"doi":"https://doi.org/10.1210/en.2006-1300","title":"Combination Therapy with the Advanced Glycation End Product Cross-Link Breaker, Alagebrium, and Angiotensin Converting Enzyme Inhibitors in Diabetes: Synergy or Redundancy?","source_url":"https://doi.org/10.1210/en.2006-1300","source_name":"Endocrinology","cited_by_count":125,"is_open_access":false,"openalex_work_id":"W1968299608","publication_date":"2006-11-16","publication_year":2006,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]},{"doi":"https://doi.org/10.1007/s00125-005-1837-9","title":"Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition","source_url":"https://doi.org/10.1007/s00125-005-1837-9","source_name":"Diabetologia","cited_by_count":43,"is_open_access":true,"openalex_work_id":"W2005362943","publication_date":"2005-07-11","publication_year":2005,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]},{"doi":"https://doi.org/10.2174/1389450054021873","title":"The Role of AGEs and AGE Inhibitors in Diabetic Cardiovascular Disease","source_url":"https://doi.org/10.2174/1389450054021873","source_name":"Current Drug Targets","cited_by_count":160,"is_open_access":false,"openalex_work_id":"W2052539295","publication_date":"2005-05-28","publication_year":2005,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]},{"doi":"https://doi.org/10.1155/2009/696378","title":"The Metal Chelators, Trientine and Citrate, Inhibit the Development of Cardiac Pathology in the Zucker Diabetic Rat","source_url":"https://doi.org/10.1155/2009/696378","source_name":"Experimental Diabetes Research","cited_by_count":32,"is_open_access":true,"openalex_work_id":"W2130132928","publication_date":"2009-01-01","publication_year":2009,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]},{"doi":"https://doi.org/10.1161/circresaha.113.300309","title":"Integrating the Myocardial Matrix Into Heart Failure Recognition and Management","source_url":"https://doi.org/10.1161/circresaha.113.300309","source_name":"Circulation Research","cited_by_count":74,"is_open_access":true,"openalex_work_id":"W2134088866","publication_date":"2013-08-29","publication_year":2013,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]},{"doi":"https://doi.org/10.2337/diabetes.53.7.1813","title":"Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis","source_url":"https://doi.org/10.2337/diabetes.53.7.1813","source_name":"Diabetes","cited_by_count":315,"is_open_access":false,"openalex_work_id":"W2147563150","publication_date":"2004-07-01","publication_year":2004,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]},{"doi":"https://doi.org/10.2337/db07-1119","title":"Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product–Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-α–Dependent Pathway","source_url":"https://doi.org/10.2337/db07-1119","source_name":"Diabetes","cited_by_count":348,"is_open_access":true,"openalex_work_id":"W2155210704","publication_date":"2007-10-24","publication_year":2007,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]},{"doi":"https://doi.org/10.1016/j.jcmg.2011.11.004","title":"Visualizing the RAGE","source_url":"https://doi.org/10.1016/j.jcmg.2011.11.004","source_name":"JACC. Cardiovascular imaging","cited_by_count":0,"is_open_access":true,"openalex_work_id":"W2202399789","publication_date":"2012-01-01","publication_year":2012,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]}],"automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}